Interference with LTβR signaling by tick saliva facilitates transmission of Lyme disease spirochetes

Lyme spirochetes have coevolved with ticks to optimize transmission to hosts using tick salivary molecules (TSMs) to counteract host defenses. TSMs modulate various molecular events at the tick-host interface. Lymphotoxin-beta receptor (LT ss R) is a vital immune receptor and plays protective roles in host immunity against microbial infections. We found that Ltbr knockout mice were more susceptible to Lyme disease spirochetes, suggesting the involvement of LT ss R signaling in tick-borne Borrelia infection. Further investigation showed that a 15-kDa TSM protein from Ixodes persulcatus (I. persulcatus salivary protein; IpSAP) functioned as an immunosuppressant to facilitate the transmission and infection of Lyme disease spirochetes. IpSAP directly interacts with LT ss R to block its activation, thus inhibiting the downstream signaling and consequently suppressing immunity. IpSAP immunization provided mice with significant protection against I. persulcatus-mediated Borrelia garinii infection. Notably, the immunization showed considerable cross-protection against other Borrelia infections mediated by other ixodid ticks. One of the IpSAP homologs from other ixodid ticks showed similar effects on Lyme spirochete transmission. Together, our findings suggest that LT ss R signaling plays an important role in blocking the transmission and pathogenesis of tick-borne Lyme disease spirochetes, and that IpSAP and its homologs are promising candidates for broad-spectrum vaccine development.

Automated summary

Lyme spirochetes have evolved with ticks to optimize transmission to hosts. They use tick salivary molecules (TSMs) to counteract host defenses. The study shows that LT ss R signaling plays an important role in blocking the transmission and pathogenesis of tick-borne Lyme disease spirochetes. A 15-kDa TSM protein called IpSAP from Ixodes persulcatus functions as an immunosuppressant to facilitate the transmission and infection of Lyme disease spirochetes. IpSAP interacts with LT ss R to block its activation, suppressing immunity.